Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2026-01-23 @ 7:34 PM
Study NCT ID:
NCT05528861
Status:
TERMINATED
Last Update Posted:
2024-09-27
First Post:
2022-09-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria
Sponsor:
Allakos Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Spontaneous Urticaria | View |